MedTrace Logo

Physiologic Study of Cerebral Perfusion

NCT02744625 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2017-03-30

No results posted yet for this study

Summary

The aim of the study is to measure cerebral perfusion using MRI in healthy subjects (with and without sedation) and in vasopressor-dependent patients

Conditions

  • Cerebral Perfusion Pressure
  • Vasopressor Agents
  • Shock
  • Magnetic Resonance Imaging (MRI), Functional

Interventions

DRUG

Higher doses of vasopressor therapy for a MAP of 75 mmHg

DRUG

Lower doses of vasopressor therapy for a MAP of 65 mmHg

DRUG

Propofol for light sedation

Propofol for light sedation

Sponsors & Collaborators

  • Centre de recherche du Centre hospitalier universitaire de Sherbrooke

    lead OTHER

Principal Investigators

  • François Lamontagne · Université de Sherbrooke

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02744625 on ClinicalTrials.gov